-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|January 16, 2018

Pseudobulbar Affect: Considerations for Managed Care Professionals

https://www.pharmacytimes.org/landing/1073

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Adam Kittai, MD

Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure

ByMaggie L. Shaw,Adam S. Kittai, MD

July 3rd 2026

Stethoscope - Angelov - stock.adobe.com

Integrated VA Care Linked to Equitable Cancer Survival for Black Veterans

ByGiuliana Grossi

July 2nd 2026

Pediatric cancer patient | Image Credit: N F/peopleimages.com - stock.adobe.com

Pediatric Cancer Carries Greater Financial Toxicity Than Adult Disease, Driving Calls for Systemic Change

ByBrooke McCormick

July 2nd 2026

Contributor: Fraud, Waste, and Abuse—A Value-Based Care Risk Hiding from Health Care Leaders

ByLuke Hansen, MD, MHS

July 2nd 2026

Delivering a vaccine to a patient | Image Credit: © guerrieroale - stock.adobe.com

Upcoming 2026-2027 Vaccine Season: Deals, Data, and an FDA Vote

July 1st 2026

Trending on AJMC

Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure

Real-World Data Show MASH Progresses Faster Than Trials Suggest

Sarcoma's Rarity Limits Trials and Biomarker-Driven Treatment Options: Alexander Spira, MD, PhD, FACP, FASCO

Kazia Therapeutics Discusses Shift for Paxalisib Into Triple-Negative Breast Cancer

SYNC-T: Immunotherapy Platform Brings 4-Part Attack in Prostate Cancer, With More Trials Planned